
FY/2020: Sales of EUR 9.3 million in Corona year in upper half of guidance - dynamic sales growth in USA (+41%); significant sales growth and positive EBITDA in trauma business planned for FY/2021
EQS Group
DGAP-News: aap Implantate AG / Key word(s): Preliminary Results/Forecast
21.01.2021 / 17:57
The issuer is solely..